Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Virtual Event

Jun 14, 2020 9:00 AM - Jun 18, 2020 5:00 PM

(Eastern Standard Time)

Fort Washington, PA 19034

DIA 2020 Global Annual Meeting

ON DEMAND - Electronic Informed Consent: Global Perspectives

Session Chair(s)

Jan  Hewett, BSN, JD

Jan Hewett, BSN, JD

Regulatory Counsel for Policy, OSI, CDER

FDA, United States

Obtaining a participant’s oral or written informed consent is only part of the overall informed consent process. Informed consent involves providing a potential research participant with adequate information about the research to allow them to make an informed decision about their voluntary participation, and it must include a process that facilitates the research participant’s comprehension of the information and allows adequate opportunity for the participant to ask questions and consider participation. As clinical trial designs have become increasingly complex, informed consent forms have likewise become increasingly complex, technical, and challenging to understand. The use of electronic informed consent (eConsent) may offer multiple advantages by using a multimedia approach to provide consistent and complete information about the clinical trial to potential participants, by permitting testing to ensure participants’ understanding, and by facilitating discussions between research participants and site staff. Additionally, use of eConsent may introduce efficiencies in the trial conduct by improving overall management of the consent process. An industry 2019 eConsent Survey will be presented and speakers will provide views on use of eConsent from regulatory, industry and research participants’ perspectives.

Learning Objective : Describe different stakeholder’s experiences and perspectives on use of electronic informed consent (eConsent) in clinical trials; Discuss potential benefits that may be achieved in the consent process with use of eConsent.

Speaker(s)

Mika  Lindroos, MSc

Informed Consent and the Emergence of eConsent: Global Perspectives and Challenges

Mika Lindroos, MSc

Signant Health, United States

Director, Product Management

Paula  Walker, MA

MHRA Perspective

Paula Walker, MA

Roche Products Ltd., United Kingdom

Global Head of Risk Based Quality Management

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.